CIP
PRAH

Chartwell Investment Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Chartwell Investment Partners’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,845
Closed -$205K – 443
2019
Q4 		$205K Sell
1,845
-43,250
-96% -$4.45M 0.01% 407
2019
Q3 		$4.47M Hold
45,095
– – 0.15% 211
2019
Q2 		$4.47M Sell
45,095
-24,949
-36% -$2.38M 0.15% 211
2019
Q1 		$7.72M Buy
70,044
+4,213
+6% +$440K 0.25% 152
2018
Q4 		$6.05M Buy
65,831
+13,187
+25% +$1.33M 0.21% 156
2018
Q3 		$5.8M Buy
52,644
+21,473
+69% +$2.24M 0.17% 192
2018
Q2 		$2.91M Sell
31,171
-1,087
-3% -$93.6K 0.09% 308
2018
Q1 		$2.68M Sell
32,258
-524
-2% -$46.6K 0.09% 252
2017
Q4 		$2.98M Sell
32,782
-2,201
-6% -$183K 0.1% 280
2017
Q3 		$2.66M Sell
34,983
-19,994
-36% -$1.51M 0.09% 279
2017
Q2 		$4.12M Sell
54,977
-40,420
-42% -$2.8M 0.15% 187
2017
Q1 		$6.22M Buy
+95,397
New +$5.62M 0.23% 149

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Chartwell Investment Partners's PRAH Position: Q1 2020 in Review

Chartwell Investment Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 1,845 shares — an estimated $205K sold.

Chartwell Investment Partners first reported a position in PRAH in Q1 2017 and held it in 12 quarters. The position peaked at $7.72M in Q1 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Chartwell Investment Partners reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Chartwell Investment Partners sold 1,845 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $205K.
  • Chartwell Investment Partners first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 12 quarters.
  • Chartwell Investment Partners's PRA Health Sciences, Inc. position peaked at $7.72M in Q1 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Chartwell Investment Partners's 13F filing for Q1 2020, filed 30 Apr 2020.